Power Law company profile

VectivBio

Biotech & Life Sciences · Basel, Switzerland · Founded 2019 · IPO 2021 Unicorn

Clinical-stage biotechnology company focused on rare conditions with a well-defined biology that can be targeted with transformational therapeutics

Valuation

$1.00B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

11 investors on VectivBio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 11 investors entered at this stage

Cowen Group

Tekla Capital Management

Cormorant Capital

Inserm Transfert Initiative

Pfizer

Bpifrance

Citadel

Eventide Asset Management

Versant Ventures

OrbiMed

Novo Holdings

Global footprint

Where VectivBio has talent and traffic

Workforce by country

🇨🇭 Switzerland · Basel HQ

Book a demo for the full country breakdown

Patent intelligence

$1M patent portfolio · 2 active families

Estimated portfolio value

$1M

0.11% of market cap · 153.1× smaller than top peer Amicus Therapeutics ($164M)

2 active patent families

Where VectivBio innovates PharmacologyPeptideGraft-versus-host diseaseGastroenterologyGastrointestines

Where VectivBio concentrates vs peers

Each axis is a top-10 topic across VectivBio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about VectivBio

An AI-synthesized read of the highest-engagement posts about VectivBio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See VectivBio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles